1222368-75-3

Basic information

• Product Name: 4-Bromo-2-(cyclopropylcarbonyl)-1-fluorobenzene
• Synonyms: 4-Bromo-2-(cyclopropylcarbonyl)-1-fluorobenzene;(5-Bromo-2-fluorophenyl)(cyclopropyl)methanone
• CAS NO: 1222368-75-3
• Molecular Formula: C10H8BrFO
• Molecular Weight: 243
• Mol File: 1222368-75-3.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-Bromo-2-(cyclopropylcarbonyl)-1-fluorobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Bromo-2-(cyclopropylcarbonyl)-1-fluorobenzene(1222368-75-3)
• EPA Substance Registry System: 4-Bromo-2-(cyclopropylcarbonyl)-1-fluorobenzene(1222368-75-3)

Safety Data

• Hazardous Substances Data: 1222368-75-3(Hazardous Substances Data)

Usage

General Description

4-Bromo-2-(cyclopropylcarbonyl)-1-fluorobenzene is a chemical compound with the molecular formula C11H8BrFO. It is a halogenated aromatic compound with a cyclopropylcarbonyl group. 4-Bromo-2-(cyclopropylcarbonyl)-1-fluorobenzene is used as a building block in the synthesis of pharmaceuticals and other organic compounds. It has potential applications in medicinal chemistry, agrochemicals, and materials science. The cyclopropylcarbonyl group confers unique reactivity and steric properties to the molecule, making it valuable in the development of new drugs and materials. Additionally, the bromo and fluoro substituents make it a versatile intermediate for further chemical modifications and functional group transformations. Overall, 4-Bromo-2-(cyclopropylcarbonyl)-1-fluorobenzene has potential as a valuable synthetic building block with diverse applications in organic and medicinal chemistry.

Upstream product

• 93777-26-5 5-bromo-2-fluorobenzaldehyde 
• 23719-80-4 cyclopropylmagnesium bromide 
• 179897-89-3 5-Bromo-2-fluoro-benzonitrile 

Downstream Products

• 911305-80-1 5-bromo-3-cyclopropyl-1H-indazole 
• 1311197-79-1 5-bromo-3-cyclopropyl-1-methyl-1H-indazole 

Relevant articles and documents

INHIBITORS OF ENL/AF9 YEATS

Methods and compositions for treating leukemia are disclosed. Acylated 6-aminoindoles, acylated 6-aminopyrrolopyridines and acylated 3-aminopyrrolo[3,2-c]pyridazines of the following formula inhibit ENL/AF9 YEATS and are therefore useful for treating leukemia.

3-AMINO-5-PHENYL-5,6-DIHYDRO-2H-[1,4]OXAZINES

The present invention relates to 3-Amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. T

2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics

A series of 2-aminothiadiazole of inhibitors of AKT1 is described. SAR relationships are discussed, along with selectivity for protein kinase A (PKA) and cyclin-dependent kinase 2 (CDK2). Moderate selectivity observed in several compounds for AKT1 versus PKA is rationalized by X-ray crystallographic analysis. Key compounds showed activity in cellular assays measuring phosphorylation of two AKT substrates, PRAS40 and FKHRL1. Compound 30 was advanced to a mouse liver PD assay, where it showed dose-dependent inhibition of AKT activity, as measured by the inhibition of phospho-PRAS40.